메뉴 건너뛰기




Volumn 11, Issue 5, 1997, Pages 464-472

Bootstrap analyses of cost effectiveness in antidepressant pharmacotherapy

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; NORTRIPTYLINE; TRAZODONE;

EID: 0030951044     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199711050-00008     Document Type: Article
Times cited : (44)

References (33)
  • 1
    • 85036447765 scopus 로고    scopus 로고
    • Effect of antidepressant therapy on health care utilization and costs in primary care
    • 1995 Jun 9; Chicago (IL). Indianapolis (IN): Eli Lilly and Company
    • Croghan TW, Lair TJ, Engelhart L, et al. Effect of antidepressant therapy on health care utilization and costs in primary care [working paper]. Association for Health Services Research Meeting; 1995 Jun 9; Chicago (IL). Indianapolis (IN): Eli Lilly and Company, 1996
    • (1996) Association for Health Services Research Meeting
    • Croghan, T.W.1    Lair, T.J.2    Engelhart, L.3
  • 3
    • 0017347943 scopus 로고
    • Foundations of cost-effectiveness analysis for health and medical practices
    • Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296: 716-21
    • (1977) N Engl J Med , vol.296 , pp. 716-721
    • Weinstein, M.C.1    Stason, W.B.2
  • 4
    • 0022589229 scopus 로고
    • Policy state areas and properties of benefit-cost/utility analysis
    • Anderson JP, Bush JW, Chen M, et al. Policy state areas and properties of benefit-cost/utility analysis. JAMA 1986; 255: 794-5
    • (1986) JAMA , vol.255 , pp. 794-795
    • Anderson, J.P.1    Bush, J.W.2    Chen, M.3
  • 5
    • 0024989695 scopus 로고
    • The CE plane: A graphic representation of cost-effectiveness
    • Black WC. The CE plane: a graphic representation of cost-effectiveness. Med Decis Making 1990; 10: 212-4
    • (1990) Med Decis Making , vol.10 , pp. 212-214
    • Black, W.C.1
  • 6
    • 8244251436 scopus 로고
    • In search of power and significance: Issues in the design and analysis of stochastic cost-effectiveness studies in health care
    • O'Brien BJ, Drummond MF, Labelle RJ, et al. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med Care 1994; 30: 231-43
    • (1994) Med Care , vol.30 , pp. 231-243
    • O'Brien, B.J.1    Drummond, M.F.2    Labelle, R.J.3
  • 8
    • 0029129619 scopus 로고
    • Use of confidence intervals and sample size calculations in health economic studies
    • Sacristan JA, Day SJ, Navarro O, et al. Use of confidence intervals and sample size calculations in health economic studies. Ann Pharmacother 1995; 29: 719-25
    • (1995) Ann Pharmacother , vol.29 , pp. 719-725
    • Sacristan, J.A.1    Day, S.J.2    Navarro, O.3
  • 9
    • 0030011253 scopus 로고    scopus 로고
    • Estimating confidence intervals for cost-effectiveness ratios: An example from a randomized trial
    • Chaudhary MA, Stearns SC. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat Med 1996; 15: 1447-58
    • (1996) Stat Med , vol.15 , pp. 1447-1458
    • Chaudhary, M.A.1    Stearns, S.C.2
  • 10
    • 84945737762 scopus 로고
    • A leisurely look at the bootstrap, jackknife and cross-validation
    • Efron B, Gong G. A leisurely look at the bootstrap, jackknife and cross-validation. Am Statistician 1983; 37: 36-48
    • (1983) Am Statistician , vol.37 , pp. 36-48
    • Efron, B.1    Gong, G.2
  • 15
    • 0026681390 scopus 로고
    • Pattern of recurrence of illness of an episode of major depression
    • Maj M, Veltro F, Pirozzi R, et al. Pattern of recurrence of illness of an episode of major depression. Am J Psychiatry 1992; 149: 795-800
    • (1992) Am J Psychiatry , vol.149 , pp. 795-800
    • Maj, M.1    Veltro, F.2    Pirozzi, R.3
  • 16
    • 0027462773 scopus 로고
    • Practice guideline for major depressive disorder in adults
    • AHCPR Guidelines. Practice guideline for major depressive disorder in adults. Am J Psychiatry 1993; 150 (2 Suppl.): 1-26
    • (1993) Am J Psychiatry , vol.150 , Issue.2 SUPPL. , pp. 1-26
  • 17
    • 0028809136 scopus 로고
    • How can care for depression become more cost-effective?
    • Sturm R, Wells KB. How can care for depression become more cost-effective? JAMA 1995; 273: 51-8
    • (1995) JAMA , vol.273 , pp. 51-58
    • Sturm, R.1    Wells, K.B.2
  • 18
    • 0026806719 scopus 로고
    • Treatments of depression and the functional capacity to work
    • Mintz J, Mintz LI, Arruda MJ, et al. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992; 49: 761-8
    • (1992) Arch Gen Psychiatry , vol.49 , pp. 761-768
    • Mintz, J.1    Mintz, L.I.2    Arruda, M.J.3
  • 20
    • 0000125534 scopus 로고
    • Sample selection as a specification error
    • Heckman J. Sample selection as a specification error. Econometrica 1979; 47 (1): 153-61
    • (1979) Econometrica , vol.47 , Issue.1 , pp. 153-161
    • Heckman, J.1
  • 24
    • 0028846528 scopus 로고
    • Direct cost of depression: Analysis of treatment costs of paroxeline versus imipramine in Canada
    • LaPierre Y, Bentkover J, Schaimbaum S, et al. Direct cost of depression: Analysis of treatment costs of paroxeline versus imipramine in Canada. Can J Psychiatry 1995; 40: 370-7
    • (1995) Can J Psychiatry , vol.40 , pp. 370-377
    • LaPierre, Y.1    Bentkover, J.2    Schaimbaum, S.3
  • 25
    • 0028789056 scopus 로고
    • Modeling the cost effectiveness of antidepressant treatment in primary care
    • Revicki DA, Brown RE, Palmer W, et al. Modeling the cost effectiveness of antidepressant treatment in primary care. Pharmacoeconomics 1995; 8: 524-40
    • (1995) Pharmacoeconomics , vol.8 , pp. 524-540
    • Revicki, D.A.1    Brown, R.E.2    Palmer, W.3
  • 26
    • 0028246430 scopus 로고
    • The cost of treatment dropout in depression: A cost-benefit analysis of fluoxetine vs. tricyclics
    • LePen C, Levy E, Ravily V, et al. The cost of treatment dropout in depression: a cost-benefit analysis of fluoxetine vs. tricyclics. J Affect Disord 1994; 31: 1-18
    • (1994) J Affect Disord , vol.31 , pp. 1-18
    • Lepen, C.1    Levy, E.2    Ravily, V.3
  • 27
    • 0028956012 scopus 로고
    • A model to evaluate the cost effectiveness of oral therapies in the management of patients with major depressive disorders
    • Einarson TR, Arikian S, Sweeney S, et al. A model to evaluate the cost effectiveness of oral therapies in the management of patients with major depressive disorders. Clin Ther 1995; 17: 136-53
    • (1995) Clin Ther , vol.17 , pp. 136-153
    • Einarson, T.R.1    Arikian, S.2    Sweeney, S.3
  • 28
    • 0003224270 scopus 로고
    • The financial implications of starting treatment with a selective serotonin reuptake inhibitor or tricyclic antidepressant in drug-naive depressed patients
    • Jonsson B, Rosenbaum J, editors. London: John Wiley & Son Ltd.
    • Boyer WF, Feighnew JP. The financial implications of starting treatment with a selective serotonin reuptake inhibitor or tricyclic antidepressant in drug-naive depressed patients. In: Jonsson B, Rosenbaum J, editors. Health economics of depression. London: John Wiley & Son Ltd., 1993: 65-75
    • (1993) Health Economics of Depression , pp. 65-75
    • Boyer, W.F.1    Feighnew, J.P.2
  • 29
    • 0028224810 scopus 로고
    • What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment
    • Jonsson B, Bebbington PE. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry 1994; 164: 665-73
    • (1994) Br J Psychiatry , vol.164 , pp. 665-673
    • Jonsson, B.1    Bebbington, P.E.2
  • 30
    • 0028149112 scopus 로고
    • Antidepressant pharmacotherapy: Economic outcomes in a health maintenance organization
    • Sclar DA, Robison LM, Skaer TL, et al. Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization. Clin Ther 1994; 16: 715-30
    • (1994) Clin Ther , vol.16 , pp. 715-730
    • Sclar, D.A.1    Robison, L.M.2    Skaer, T.L.3
  • 31
    • 0029040591 scopus 로고
    • Economic valuation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of patients with depression
    • Skaer TL, Sclar DA, Robison LM, et al. Economic valuation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of patients with depression. Curr Ther Res 1995; 56: 556-67
    • (1995) Curr Ther Res , vol.56 , pp. 556-567
    • Skaer, T.L.1    Sclar, D.A.2    Robison, L.M.3
  • 32
    • 0029922652 scopus 로고    scopus 로고
    • Initial antidepressant choice: Effectiveness and cost of fluoxetine vs tricyclic antidepressants
    • Simon GE, VonKorff M, Heiligenstein JH, et al. Initial antidepressant choice: effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 1996; 275: 1897-902
    • (1996) JAMA , vol.275 , pp. 1897-1902
    • Simon, G.E.1    Vonkorff, M.2    Heiligenstein, J.H.3
  • 33
    • 8244221026 scopus 로고
    • Limit theorem, central
    • Johnson NL, Kotz J, Read CB, editors. New York: John Wiley and Sons
    • Heyde CC. Limit theorem, central. In: Johnson NL, Kotz J, Read CB, editors. Encyclopedia of statistical sciences. Vol 4, New York: John Wiley and Sons, 1982: 651-5
    • (1982) Encyclopedia of Statistical Sciences , vol.4 , pp. 651-655
    • Heyde, C.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.